Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therap...

Luye Life Sciences Group Shanghai Office Relocation Notice

Luye Life Sciences Group Shanghai Office will be relocated to Hongqiao Road 1438, Changning District from June...

Marketing Authorization Application Accepted by CDE for Luye Pharma’s Antidepressant Ansh...

Luye Pharma’s Innovative Alzheimer’s Disease Therapy Rivastigmine Multi-Day Transdermal ...

Bringing new treatment option to patients.

Boan Biotech's 博优诺® Obtains Marketing Authorization in China

The third biosimilar of Avastin® to enter the market in China

GeneLeap Presents the Synthesis of a Novel GalNAc at ACS 2021

The results showed that the novel GalNAc moieties are more convenient and affordable.Compared with the traditi...